To investigate the probability of developing type 2 diabetes mellitus (T2DM) at different body mass index levels compared to matched non-diabetic controls in a multi-ethnic population.
investigating association with mortality and morbidity, primarily in a White population. However, there is increasing evidence that levels of risk associated with the classification of overweight and obesity vary across ethnic groups. [6] [7] [8] [9] [10] [11] The propensity to develop T2DM varies considerably among ethnic groups and identifying the BMI cut points within specific ethnic groups at which the risk of T2DM increases is useful to inform public health policy. Some studies have evaluated the ethnicity-specific diabetes incidence rates in association with prior BMI levels using population level and primary care data. 7, 9, 12, 13 These studies were limited by the number of subjects in the non-white ethnic groups. The pooled analysis of survey data from various countries conducted by the DECODE-DECODA study group in 2003 evaluated the association of ethnicity, BMI and prevalence of T2DM. 13 However, BMI measurements were not taken consistently at the time of diagnosis of diabetes. Only 1 previous study has compared the distribution of BMI at diagnosis of T2DM with non-diabetic controls. 5 Ganz and colleagues defined BMI at diagnosis as the last measurement of BMI taken within 1 year prior to diagnosis of T2DM, and randomly matched controls to cases. 5 While this study reported increased risk of developing T2DM with higher BMI levels, the differential aspects of ethnicity in the relationship between BMI and risk were not addressed.
No study has compared the distribution of BMI at diagnosis of T2DM by ethnicity with non-diabetic controls. In addition, we are not aware of any population-based study evaluating differences in the risk of developing T2DM in men and women of different age levels between different ethnic groups over the entire spectrum of BMI distribution at diagnosis. Using a large cohort of incident T2DM
patients, and an age-sex-ethnicity matched non-diabetic control cohort from UK primary care, the aims of this study were to evaluate for each ethnic group (1) the distribution of BMI, glycaemic and vascular risk factors at diagnosis of T2DM, and (2) the probability of developing T2DM over the entire spectrum of BMI and age.
| MATERIALS AND METHODS

| Data source
Data for this study were obtained from The Health Improvement Network (THIN) database, a large anonymized longitudinal dataset derived from a network of more than 600 primary care providers across the UK. With longitudinal data on approximately 11 million individuals registered with the primary care system, the THIN database has been used extensively for academic research in various disciplines. 14 The accuracy and completeness of this database have been described previously. 15, 16 Notably, the database has a similar distribution of major chronic diseases including diabetes, heart failure and obesity when compared to UK national statistics. 16 
| Identification of T2DM cases
Patients with T2DM were identified through various steps of clinically guided iterative processes. Specifically, T2DM cases were selected if: White Europeans (26%) and African-Caribbeans (29%) (all P < .01).
| Statistical analysis
Those not included in the study because of non-availability of ethnicity data were older (mean age, 61 years compared to 56 years in the study cohort) but had a similar distribution of sex, BMI and smoking status (current smokers, ex-smokers, never smokers).
The average SBP in South Asians at the time of diagnosis of T2DM (132 mm Hg) was significantly lower, with only 20% having SBP ≥140 mm Hg, compared to the 2 other ethnic groups (P < .01).
Among those who developed T2DM, only 28% of South Asians were current or ex-smokers at index date, compared to 60% and 33% in the White and African-Caribbean ethnic groups, respectively. AfricanCaribbeans and South Asians had significantly higher LDL-C levels at diagnosis of T2DM (LDL-C ≥ 100 mg/dL; 34% and 28%, respectively) compared to White Europeans (LDL-C ≥ 100 mg/dL; 23%) ( Table 1 ).
African-Caribbeans had significantly higher mean HbA1c levels at diag- Distributions of BMI at diagnosis of T2DM in different ethnic groups, by age group at diagnosis, are presented in Table 2 . South
Asians and African-Caribbeans aged 18 to 70 years at diagnosis developed T2DM at a significantly lower BMI than White Europeans.
Over the entire distribution of BMI levels, the probability of developing T2DM in South Asians compared with other ethnic groups, determined separately for male and female and by different age groups, is presented in Figures 1 and 2 , respectively. When analysed with continuous measure of BMI, compared to both White Europeans and African-Caribbeans, South Asians had a significantly higher probability of developing T2DM within the range of BMI from 18 to c. 30 kg/m 2 , for both men and women ( Figure 1A-D) . The adjusted probability (95% CI) of developing T2DM at different BMI category levels compared between the 3 ethnic groups, separately for different age groups, is presented in Figure S2 . Across all age groups under the age of 70 years, South Asians and African-Caribbeans had a significantly higher probability of developing T2DM in the normal weight and overweight categories, compared to White Europeans.
Sensitivity analysis with extended list of covariates revealed similar results.
Given the different patterns of risk of developing T2DM among obese patients between ethnic groups across different age groups ( Figure S2 ), we evaluated the odds of developing T2DM in AfricanCaribbeans and South Asians, compared to White Europeans, separately for each age group. Within each age group, the probability of developing T2DM was greater among South Asians at a lower BMI. 6724 (9) 26 896 (9) 949 (23) 3796 (23) 2204 (30) 8816 (30) 9877 (11) 39 508 (11) 41 to 50 15 614 (20) 62 456 (20) 1511 (37) 6044 (37) 2598 (36) 10 392 (36)
19 723 (22) 78 892 (22) 51 to 60 22 425 (28) 89 700 (28) 1007 (25) 4028 (25) 1529 (21) 6116 (21) 24 961 (28) 99 844 (28) 61 to 70 21 751 (27) 87 004 (27) 491 (12) 1964 (12) 688 (10) 2752 ( (16) 157 (4) 628 (4) 233 (3) 932 ( 59 060 (19) 527 (13) 2307 (14) 967 (13) 3460 (12 808 (20) 2612 (16) 1058 (15) 3497 ( (5) 564 (14) 1954 (12) 665 (9) 2525 (9) 4620 (5) 19 533 (5) Lowest affluence a 16 923 (21) 56 124 (18) 994 (24) 4290 (26) 1852 (26) 7073 (24 (8) 365 (9) 834 (5) 921 (13) 2374 (8) 6244 (7) 27 260 (8)
Overweight a 15 439 (20) 30 135 (10) 820 (20) 1283 (8) 1830 (25) 2376 (8) 18 089 (20) 33 794 (9) Grade 1 obese a 15 592 (20) 13 654 (4) 719 (18) 764 (5) 1050 (15) 896 (3) 17 361 (19) 15 314 (4)
Grade 2 obese a 8973 (11) 4073 (1) 383 (9) 288 (2) 386 (5) 251 (1) 9742 (11) 4612 (1) SBP (17) 1104 (27) 1742 (11) 1461 (20) 2092 (7) 31 (8) 1388 (34) 1531 (9) 2003 (28) 2684 (9) 21 335 (24) 29 543 (8) (Continued ) (4) 924 (23) 501 (3) 2041 (28) 1452 (5 (4) 601 (15) 260 (2) 1681 (23) 1316 ( 4493 (1) 52 (1) 146 (1) 34 (1) 143 (1) 1838 (2) 4782 (1) Cancer 4746 (5) 18 793 (6) 100 (2) 278 (2) 68 (1) 339 (1) 4914 (5) 19 410 (5) Myocardial infarction 4802 (6) 9120 (3) 34 (1) 85 (1) 181 (3) 355 (1) 5017 (6) 9560 (3) Heart failure 1743 (2) 2635 (1) 29 (1) 38 (0) 41 (1) 76 (<0.1)
1813 (2) 2749 (1) Angina 6529 (8) 12 975 (4) 48 (1) 93 (1) 196 (3) 440 (2) 6773 (8) 13 508 (4) Stroke 4014 (5) 9521 (3) 105 (3) 198 (1) 111 (2) 275 (1) 4230 (5) 9994 (3) Any CVD 15 769 (20) 33 155 (11) 225 (6) 443 (3) 519 (7) 1101 ( (20) 1419 (35) 2852 (17) 1803 (25) 2941 ( (18) 622 (15) 1411 (20) 16 514 (18) GLP1-RA 3769 (5) 117 (3) 225 (3) 4111 (5) DPP-4 11 078 (14) 633 (15) 1231 (17) 12 942 (14) Alpha glucosidase
(2)
58 (1) 117 (2) 1720 (2) SGLT2 615 (1) 21 (1) 59 (1) 695 (1) Metglinides 902 (1) 58 (1) 100 (1) 1060 (1) Other medications (ever prescribed) a Antihypertensive 3577 (5) 7496 (2) 173 (4) 390 (2) 145 (2) 320 (1) 3895 (4) 8206 (2) Diuretics 20 688 (26) 41 226 (13) 585 (14) 1421 (9) 684 (9) 1508 (5) 21 957 (24) 44 155 (12) Beta blockers 18 938 (24) 42 580 (13) 427 (10) 1103 (7) 758 (11) 1913 (7) 20 123 (22) 45 596 (13) Calcium blockers 15 070 (19) 30 059 (10) 724 (18) 1588 (10) 703 (10) 1386 (5) 16 497 (18) 33 033 (9) Statins 19 376 (24) 35 419 (11) 627 (15) 811 (5) 1219 (17) 1679 (6) 21 222 (23) 37 909 (11) Ace inhibitors 17 145 (22) 30 152 (10) 558 (14) 889 (5) 823 (11) 1370 (5) 18 526 (20) 32 411 (9) CPMs 34 595 (44) 73 919 (23) 1272 (31) 2473 (15) 1997 (28) 3671 (13) 37 864 (42) 80 063 (22) (Continued ) of OR: 0.57, 0.78) and 35% (95% CI of OR: 0.52, 0.82) lower adjusted odds of developing T2DM in the respective age groups. However, these odds were not statistically significantly different between African-Caribbeans and South Asians (Table S2) . , respectively at diagnosis. 5 With similar age at diagnosis of T2DM, our UK study cohort had a significantly lower BMI level (32 kg/m 2 ). However, this distribution of BMI at diagnosis is consistent with other studies reporting BMI at diagnosis of T2DM in the UK population. [23] [24] [25] Similarly, our finding that women developed T2DM at a significantly higher BMI level compared to men, across ethnicity, is consistent with earlier reports. 26, 27 Earlier studies have shown that the onset of T2DM occurs up to a decade earlier amongst South Asians. A Canadian cohort-based diabetes incidence study reported that the median age at diagnosis was lowest among South Asians (49 years), followed by AfricanCaribbeans (57 years) and White Europeans (58 years). 9 Our data are consistent with these observations and, on average, South Asians were 12 years younger at diagnosis compared to their White European counterparts. Factors that influence the predisposition of South Asians to develop T2DM at a younger age are largely unknown and may be related to a combination of genetic and environmental factors that
| DISCUSSION
have not yet been fully characterized.
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Ganz and colleagues reported in 2014 significantly increasing odds of developing T2DM with increasing BMI. 5 While this study also evaluated the risk of developing T2DM in various age groups using additive models, the interaction of age and body weight in the risk of developing T2DM was not explored. Given that age and obesity are 2 major risk factors for T2DM, we explored the interaction of age and BMI levels (separately for male and female) in evaluating the risk of developing T2DM across the 3 ethnic groups. One of the novelties of this study is comparative exploration of the probability of developing T2DM over the whole continuous distribution, as well as categories of BMI by ethnic groups. When BMI was analysed as a continuous variable, we found that South Asians aged 40 years and above had a significantly greater probability of T2DM at lower BMI Earlier ethnicity-specific studies evaluating the association of prior BMI with incident rates of T2DM reported higher risk in South Asians at a lower BMI level. 7, 9, 28 During a median follow-up of 6 years, Chui and colleagues reported higher T2DM incidence rates in South Asians at lower ages and BMI levels compared to White Europeans. 9 A similar observation was made in another follow-up study reported by Tillin and colleagues. 7 Our study elaborates on the significantly higher likelihood of developing T2DM at lower BMI levels among South Asians, compared to White Europeans and African-Caribbeans. We have also identified a significant change in The P values are estimated to present the significance of differences in the distribution of BMI between each combination of 2 ethnic groups. The proportions of patients under different obesity grades are presented by number (%).
Abbreviations: AC, African-Caribbean; SA, South Asian; WE, White European. a n (%).
b Mean AE SD.
the risk pattern at higher BMI levels when compared between ethnic groups at different age levels (Figures 2 and S2 ). Additionally, our study provides detailed information on the contrasting probability of developing T2DM in different age and ethnicity groups across the entire spectrum of BMI. There are several possible explanations for the contrasting effects of obesity on probability of diabetes among ethnic groups. While BMI is an accepted measure of obesity, this does not differentiate between patterns of obesity (visceral vs subcutaneous). It is well known that South Asians have excess visceral adiposity, even at lower BMI levels, which may explain the higher propensity of South Asians to develop T2DM at lower BMI levels.
However, that pattern would be expected to persist at even higher levels of BMI and, therefore, South Asians would be expected to have a greater risk in comparison with White Europeans, for any level of BMI. Our observation that this difference is evident only at lower BMI levels, but not at higher BMI ranges, would suggest that excess visceral adiposity alone does not explain this variance. An alternative explanation could be that the relative contribution of obesity to risk of T2DM may be greater among White Europeans compared to that in South Asians and that the risk of T2DM in South Asians may be determined additionally by underlying beta cell dysfunction. Clearly, this needs to be addressed in future studies.
The strength of this study is that it includes: (1) a large number of T2DM patients from a primary care system, many of whom are South Asian; (2) a representative age-and sex-matched non-diabetic control cohort; (3) use of anthropometric, clinical risk factor measures at index date; and (4) a robust analysis approach to explore potential interactions between age, sex and BMI in different ethnic groups.
Patient-level data from electronic health records present challenges in terms of accuracy and completeness of study variables of interest.
The limitations of this study include: (1) availability of ethnicity data on a limited number of patients; (2) missing risk factor data; (3) potential for residual confounding; and (4) inability to draw a causal link between BMI and T2DM, as with all observational studies. However, ethnicity recording for South Asians and African-Caribbeans in the electronic database used for this study is comparable to that for the general population of the UK. 29 We also attempted to minimize bias introduced by confounders through the use of multivariate models with a detailed list of possible confounders. However, unavailability of information on education, physical activity, diet and other risk factors may have introduced bias into the risk estimates.
To conclude, the South Asian and African-Caribbean populations have an increased burden of T2DM with its complications. In this large case-control data analysis we have demonstrated that T2DM occurs in South Asians at least 12 years earlier, at a mean age of 46 years, as compared to White Europeans, with about one third developing T2DM under the age of 40 years. We believe that the early presentation of diabetes in this population contributes to the glycaemic load and the burden of complications. Hence, early diagnosis of diabetes, and recognition of the lower age of presentation, may help to ameliorate the glycaemic burden. To accomplish this, a lowerage cut-off for screening in national programmes for South Asians is FIGURE 1 Association between BMI at diagnosis and risk of T2DM (95% CI), compared between 3 groups of ethnicity. A, Adjusted probability of developing T2DM (95% CI) at different levels of BMI for male South Asians, compared to male White Europeans. B, Adjusted probability of developing T2DM (95% CI) at different levels of BMI for female South Asians compared to female White Europeans. C, Adjusted probability of developing T2DM at different BMI levels for male South Asians compared to male African-Caribbean. D, Adjusted probability of developing T2DM at different BMI levels for female South Asians compared to female White Europeans. Probability estimated in A, B, C and D is adjusted for age, smoking status, deprivation score and history of CVD, cancer and CKD on or prior to the index date required. This is the first large cohort that we are aware of in which it has been demonstrated that South Asians develop diabetes at a mean lower BMI by 5 kg/m 2 when compared to White Europeans. This has implications in terms of both diagnosis of obesity in South Asians and appropriate management interventions.
